Virionyx- MIS416

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Virionyx- MIS416

Postby jam » Mon Dec 22, 2008 3:27 pm

Need your help. Has anyone heard of this? I have been asked to participate in trials in NZ. Apparently they have had good results with this drug. I spoke to a lady who was treated and she has had good reults. She could not intially stand, was wheelchair bound and could not lift her arms above her head.

She can now stand and lift her arms up.

Any feedback welcomed.


Jam
User avatar
jam
Family Member
 
Posts: 67
Joined: Fri Oct 24, 2008 3:00 pm

Advertisement

Postby dignan » Mon Dec 22, 2008 4:48 pm

Jam, I just had a look around and I found no evidence that it is even being considered specifically as an MS treatment. The only mention of this drug candidate and autoimmune diseases I found was that the company founder suffers from "an auotimmune disease" (didn't say which disease) and has been using this for 10 years. It hasn't undergone any trials that I could find. Sorry I didn't have anything more helpful to share.
User avatar
dignan
Family Elder
 
Posts: 1608
Joined: Wed Aug 11, 2004 3:00 pm

Postby Nemotoday » Tue Dec 23, 2008 1:32 pm

http://www.nbr.co.nz/article/virionyx-d ... ital-38222

This company were originally working with a treatment for HIV.

I found this

Virionyx director in USA taps investors for further capital
NZPA | Monday November 24 2008 - 07:37pm

An American director of Virionyx, a New Zealand biopharmaceutical company testing a new anti-AIDS drug in India, has been helping raise cash for the company in the United States.

Chris Collins, one of four unpaid directors at Virionyx, is seeking more capital from the company's American investors, the Buffalo City News reported.

South Auckland-based Virionyx has poured over $40 million of investors' funds into not only its Aids drug, HRG214, but other targets such as Trithrax, an anthrax vaccine it hopes to sell to the US Government at $US5000 ($NZ9569.37) a dose.

HRG214 and Trithrax exploit the fact that goats have better immunity to some micro-organisms than humans.

Most of the money so far spent by the company has come from New Zealand investors.

According to its website more than 80 percent of the 1550 shareholders are New Zealand residents, but the US-based private investors own a stake of about 25 percent.

Mr Collins, who has a day job as Erie County's elected chief executive, is Virionyx's lead investor in the US.

He recently gathered about 20 other investors for a brunch at the Brookfield Country Club.

Virionyx said two years ago it was eyeing a United States listing, after selling a 16.8 percent stake for $US6m to American investors.

It wanted to raise a total of $US7.5 million for operational funding, to pay back $1.5 million in debt, and cover the cost of phase II trials of HRG214 -- and said it hoped to raise the additional $US1.5m from New Zealand shareholders at $1.50/share.

Mr Collins said doctors, scientists, friends and neighbours in suburban Buffalo had put their money into Virionyx at his suggestion.

Virionyx began an American joint venture, Buckler Biodefense Corp, with a Buffalo company Zeptometrix, in 2005, when the American company was headed by Mr Collins.

In addition to the anthrax vaccine, it has also been working on an emergency therapy for acute radiation-induced neutropenia, a condition which often precedes leukaemia.
Keep smiling as who knows what good things might be around the corner and if the road snakes a bit keep going.
User avatar
Nemotoday
Family Member
 
Posts: 72
Joined: Fri May 21, 2004 3:00 pm

Virionyx

Postby jam » Sun Dec 28, 2008 5:54 pm

Thanks for the replies. I have been asked to participate in a trial with this medication. I think I will - don't have too much to lose but possibly e/thing to gain.

Let me know what you think. I will be injected weekly!

Jam
User avatar
jam
Family Member
 
Posts: 67
Joined: Fri Oct 24, 2008 3:00 pm

Postby Cojack » Mon Jan 05, 2009 6:29 pm

Hi Jam,

good luck & keep us posted!

jack
User avatar
Cojack
Family Member
 
Posts: 63
Joined: Tue Nov 11, 2008 4:00 pm

MIS416 just published info

Postby fishfingers » Wed Jan 28, 2009 1:13 pm

I'm very interested to find out what info is available on the web regarding MIS416. I just googled today and found your discussion along with an article published in a US Biotech magazine. This is a very heavy read but may be of interest....

<shortened url>

If the link is slow opening up just try typing virionyx into the biopharm website and it will find and display the article.
User avatar
fishfingers
Newbie
 
Posts: 1
Joined: Tue Jan 27, 2009 4:00 pm

Re: Virionyx

Postby ljh » Tue May 11, 2010 7:46 pm

jam wrote:Thanks for the replies. I have been asked to participate in a trial with this medication. I think I will - don't have too much to lose but possibly e/thing to gain.

Let me know what you think. I will be injected weekly!

Jam


Hi JAM- Did you go on MIS416?? What happened? How did it go for other people?
User avatar
ljh
Getting to Know You...
 
Posts: 11
Joined: Fri Mar 26, 2010 4:00 pm


Return to Drug Pipeline

Who is online

Users browsing this forum: No registered users